Federal Register / Vol. 82, No. 247 / Wednesday, December 27, 2017 / Notices 61309 

Dated: December 20, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–27937 Filed 12–26–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant and/or contract 

proposals applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

and/or contract proposals applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI SPORE 

II Review. 

Date: January 29–30, 2018. 

Time: 4:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Klaus B. Piontek, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W612, 

Bethesda, MD 20892–9750, 240–276–5413, 

klaus.piontek@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Cancer 

Cachexia Therapy and Local Delivery of 

Chemopreventive Agents. 

Date: February 8, 2018. 

Time: 9:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W030, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Jun Fang, Ph.D., Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W246, Bethesda, MD 20892–9750, 

240–276–5460, jfang@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–6: 

Modified RNA and Oncosomes. 

Date: February 14, 2018. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W114, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Jeffrey E. DeClue, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W114, Bethesda, MD 20892– 

9750, 240–276–6371, decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project I. 

Date: February 20–21, 2018. 

Time: 4:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Klaus B. Piontek, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W612, 

Bethesda, MD 20892–9750, 240–276–5413. 

klaus.piontek@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Imaging 

Radiation and Immunotherapies. 

Date: February 20–21, 2018. 

Time: 6:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Jun Fang, Ph.D., Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W246, Bethesda, MD 20892–9750, 

240–276–5460, jfang@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Biological 

Comparisons in Patient-Derived Models of 

Cancer. 

Date: February 23, 2018. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W236, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Robert S. Coyne, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W236, Bethesda, MD 

20892–9750, 240–276–5120, coynes@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; TEP–2: 

Software Tools & Sensors for the Cancer 

Therapeutics. 

Date: February 28–March 1, 2018. 

Time: 5:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hilton Washington DC/Rockville 

Hotel, 1750 Rockville Pike, Bethesda, MD 

20852. 

Contact Person: Nadeem Khan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH 9609 Medical Center 

Drive, Room 7W260, Bethesda, MD 20892– 

9750, 240–276–5856, nadeem.khan@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–1 for 

Provocative Questions. 

Date: March 1, 2018. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Byeong-Chel Lee, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH 9609, Medical Center Drive, 

Room 7W238, Bethesda, MD 20892–9750, 

240–276–7755, byeong-chel.lee@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, NCI 

Clinical and Translational Exploratory/ 

Developmental Studies. 

Date: March 1–2, 2018. 

Time: 5:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Zhiqiang Zou, MD, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W242, Bethesda, MD 

20892–9750, 240–276–6372, zouzhiq@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI R03 & 

Clinical and Translational R21: SEP–1A. 

Date: March 29, 2018. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W260, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Nadeem Khan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities National, 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W260, Bethesda, MD 20892– 

9750, 240–276–5856, nadeem.khan@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 


daltland on DSKBBV9HB2PROD with NOTICES
61310 Federal Register / Vol. 82, No. 247 / Wednesday, December 27, 2017 / Notices 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 20, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–27939 Filed 12–26–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Partnerships for 

Development of Clinically Useful Diagnostics 

for Antimicrobial-Resistant Bacteria (R01). 

Date: January 18, 2018. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Lynn Rust, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

room 3G42A, National Institutes of Health/ 

NIAID, 5601 Fishers Lane, MSC 9823, 

Bethesda, MD 20892–9823, (240) 669–5069, 

lrust@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Clinical Trial 

Implementation Cooperative Agreement 

(U01). 

Date: January 19, 2018. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Nancy VazquezMaldonado, Ph.D., Scientific Review Officer, 

Scientific Review Program, Division of 

Extramural Activities, Room 3F52B National 

Institutes of Health/NIAID, 5601 Fishers 

Lane, MSC 9823, Bethesda, MD 20892–9823, 

240) 669–5044, nv19q@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 21, 2017. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–27938 Filed 12–26–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2017–1009] 

Commercial Fishing Safety Advisory 

Committee 

AGENCY: U.S. Coast Guard, Department 

of Homeland Security. 

ACTION: Request for applications. 

SUMMARY: The U.S. Coast Guard seeks 

applications for membership on the 

Commercial Fishing Safety Advisory 

Committee. The Commercial Fishing 

Safety Advisory Committee provides 

advice and makes recommendations to 

the Coast Guard and the Department of 

Homeland Security on various matters 

relating to the safe operation of 

commercial fishing industry vessels. 

Both positions were previously 

advertised under Docket No. USCG– 

2017–0829 but no applications for either 

of the two positions were received. 

DATES: Completed applications should 

be submitted to the U.S. Coast Guard on 

or before February 26, 2018. 

ADDRESSES: Applicants should send a 

cover letter expressing interest in an 

appointment to the Commercial Fishing 

Safety Advisory Committee that also 

identifies which membership category 

the applicant is applying under, along 

with a resume detailing the applicant’s 

experience via one of the following 

methods: 

• By Email: Jonathan.G.Wendland@

uscg.mil, Subject line: The Commercial 

Fishing Safety Advisory Committee. 

• By Mail: Commandant (CG–CVC– 

3)/CFSAC, Attn: Mr. Jonathan 

Wendland, U.S. Coast Guard, 2703 

Martin Luther King Ave. SE, Stop 7501, 

Washington, DC 20593–7501. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Jonathan Wendland, Alternate 

Designated Federal Officer of the 

Commercial Fishing Safety Advisory 

Committee, 202–372–1245 or 

Jonathan.G.Wendland@uscg.mil. 

SUPPLEMENTARY INFORMATION: The 

Commercial Fishing Safety Advisory 

Committee is a federal advisory 

committee which operates under the 

provisions of the Federal Advisory 

Committee Act, (Title 5, U.S.C. 

Appendix). The U.S. Coast Guard 

chartered the Commercial Fishing 

Safety Advisory Committee to provide 

advice on issues related to the safety of 

commercial fishing industry vessels 

regulated under Chapter 45 of title 46, 

United States Code, which includes 

uninspected fish catching vessels, fish 

processing vessels, and fish tender 

vessels. (See Title 46 U.S.C. 4508.) 

The Commercial Fishing Safety 

Advisory Committee meets at least once 

a year. It may also meet for other 

extraordinary purposes. Its 

subcommittees or working groups may 

communicate throughout the year to 

prepare for meetings or develop 

proposals for the committee as a whole 

or to address specific tasks. 

Each member serves for a term of 

three years. An individual may be 

appointed to a term as a member more 

than once, but not more than two terms 

consecutively. All members serve at 

their own expense and receive no salary 

or other compensation from the Federal 

Government, although travel 

reimbursement and per diem may be 

provided for called meetings. 

The U.S. Coast Guard will consider 

applications for two (02) positions that 

will be vacant on January 2018 in the 

following categories: 

(a) An individual who represents the 

general public, a marine surveyor who 

provides services to vessels to which 

Chapter 45 of Title 46 U.S.C. applies 

(one position); 

(b) An individual who represents 

manufacturers of equipment for vessels 

to which Chapter 45 of Title 46, U.S.C. 

applies (one position); 

If you are selected as a member from 

the general public, you will be 

appointed and serve as a Special 

Government Employee as defined in 

Section 202(a) of Title 18, U.S.C. 

Applicants for appointment as a Special 

Government Employee are required to 

complete a Confidential Financial 

Disclosure Report (OGE Form 450). The 

U.S. Coast Guard may not release the 

reports or the information in them to the 

public except under an order issued by 

a Federal court or as otherwise provided 

under the Privacy Act (5 U.S.C. 552a). 

Only the Designated U.S. Coast Guard 

Ethics Official or his or her designee 

may release a Confidential Financial 

Disclosure Report. Applicants can 

obtain this form by going to the website 

of the Office of Government Ethics 

(www.oge.gov), or by contacting the 


daltland on DSKBBV9HB2PROD with NOTICES